VERA - Vera Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERA is currently covered by 7 analysts with an average price target of $51.6. This is a potential upside of $23.9 (86.28%) from yesterday's end of day stock price of $27.7.

Vera Therapeutics's activity chart (see below) currently has 11 price targets and 42 ratings on display. The stock rating distribution of VERA is 87.88% BUY and 12.12% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.6% with an average time for these price targets to be met of 138.38 days.

Highest price target for VERA is $107, Lowest price target is $38, average price target is $63.57.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 04-Mar-2025. First documented stock forecast 08-Jun-2021.

Currently out of the existing stock ratings of VERA, 29 are a BUY (87.88%), 4 are a HOLD (12.12%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$71

$43.01 (153.66%)

$75

15 days ago
(04-Mar-2025)

5/11 (45.45%)

$42.59 (149.91%)

271

Buy

$61

$33.01 (117.93%)

$64

20 days ago
(27-Feb-2025)

1/5 (20%)

$31.59 (107.41%)

163

Hold

$38

$10.01 (35.76%)

$34

4 months 11 days ago
(08-Nov-2024)

6/7 (85.71%)

$-10.09 (-20.98%)

148

Buy

$75

$47.01 (167.95%)

$20

4 months 19 days ago
(28-Oct-2024)

3/4 (75%)

$27.66 (58.43%)

252

Buy

$107

$79.01 (282.28%)

$107

5 months 18 days ago
(01-Oct-2024)

0/4 (0%)

$64.17 (149.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERA (Vera Therapeutics) average time for price targets to be met?

On average it took 138.38 days on average for the stock forecasts to be realized with a an average price target met ratio 61.6

Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?

LIISA BAYKO

Which analyst has the current lower performing score on VERA (Vera Therapeutics) with a proven track record?

VAMIL DIVAN

Which analyst has the most public recommendations on VERA (Vera Therapeutics)?

Liisa Bayko works at EVERCORE and has 12 price targets and 9 ratings on VERA

Which analyst is the currently most bullish on VERA (Vera Therapeutics)?

Pete Stavropoulos with highest potential upside - $79.01

Which analyst is the currently most reserved on VERA (Vera Therapeutics)?

Maury Raycroft with lowest potential downside - -$21.46

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?